Consultation with FP/SRH Stakeholders on the Dual Prevention Pill - Family Planning 2030

Contact Subscribe

Make a Commitment

English

About
About FP2030
Working together to advance family planning around the world.

Learn more
What We Do Our Strategy History Our Team FP2030 Board PME Working Group Careers and Internships
Focus Areas
Focus Areas
Working towards global reproductive choice; autonomy and empowerment; and gender equality.

Learn more
Adolescents & Youth Civil Society Engagement Emergency Preparedness & Response Faith & Family Planning Gender Postpartum & Post-Abortion Family Planning Measurement Learning Series Understanding Additional Users Return on Investment (ROI)
Regional Hubs
Regional Hubs
Supporting country-specific goals with ties to global family planning.

Learn more
Asia and Pacific East and Southern Africa Latin America and the Caribbean North America and Europe North, West and Central Africa
Commitment Makers
Commitment Makers
Creating a future for women and girls with the freedom and ability to lead healthy lives.

Learn more
Government Non-Government Donors Make a commitment
Data Hub
Data Hub
We believe in the power of data to drive results and measure impact.

Learn more
Get Data FP2030 Measurement Framework Focus Areas
Impact
Impact
Empowering accessible rights-based, family planning all over our world.

Learn More
Measurement Report Impact News and Resources Partnership Fund Partnership Fund Winners
Knowledge Center
Knowledge Center
Browse our library for the latest news and resources.

Learn More
Browse All News Resources Videos and Webinars Podcasts Toolkits

Get Involved

Empowering the voluntary use of modern contraception around the world.

Make a Commitment

For Governments For Non-Governments For Donors

Become a Funder Subscribe to Newsletter Contact

Videos & Webinars

Consultation with FP/SRH Stakeholders on the Dual Prevention Pill

Integrating FP & HIV Services

Previous

FP2030 is landing in Lati...

Next

Working Together to Trans...

On April 12, AVAC and FP2030 convened a consultation with family planning (FP) and sexual and reproductive health (SRH) stakeholders to understand their unique perspectives on the Dual Prevention Pill (DPP), a daily oral pill that prevents HIV and pregnancy. The consultation helped to elevate questions and issues to consider as DPP introduction plans are refined and that can also inform the development and delivery of future multi-purpose prevention technologies (MPTs).

Additional Resources